¹Ýµð¾Ø·ç´Ï½º ÀÎÅͳݼ­Á¡

³×ºñ°ÔÀÌ¼Ç ½Ç½Ã°£ Àαâ Ã¥

    Æò°¡À§¿ø °üÁ¡ÀÇ »ç¾÷°èȹ¼­

    Æò°¡À§¿ø °üÁ¡ÀÇ »ç¾÷°èȹ¼­

    • ±èâȭ, ¹ÚÁؼö Àú
    • Çѱ¹ÇмúÁ¤º¸
    • 2020³â 04¿ù 01ÀÏ
    • Á¤°¡
      17,000¿ø
    • ÆÇ¸Å°¡
      15,300¿ø [10% ÇÒÀÎ]
    • °áÁ¦ ÇýÅÃ
      ¹«ÀÌÀÚ
    • Àû¸³±Ý
      850¿ø Àû¸³ [5%P]

      NAVER Pay °áÁ¦ ½Ã ³×À̹öÆäÀÌ Æ÷ÀÎÆ® 5% Àû¸³ ?

    ǰÀýµÈ »óǰÀÔ´Ï´Ù.

    À§½Ã¸®½ºÆ®
    ȸ¿ø¸®ºä
    - [0]
    ISBN: 9788926898475 205ÂÊ 188 x 257 (§®)

    Áö±Ý ÀÌÃ¥Àº

    • ÆÇ¸ÅÁö¼ö : 380

    ÀÌ ºÐ¾ßÀÇ º£½ºÆ®¼¿·¯

    ÀÌ Ã¥ÀÌ ¼ÓÇÑ ºÐ¾ß

    ÀúÀÚ ¼Ò°³

    ±èâȭ, ¹ÚÁؼö

    ÀúÀÚ : ±èâȭ
    £¿ °æ·Â
    ¾Æ¸®¿ï±â¼úÅõÀÚ¢ß
    ¢ß°í»êÅ×Å© ±â¾÷ºÎ¼³¿¬±¸¼Ò
    ¢ß¿ì¸®»ý¸í°úÇпø
    ¢ß¿£À¯¾¾ÀüÀÚ ÀÇ·á»ç¾÷ºÎ
    ¢ß´ë¼ºÇÏÀÌÅØ ¸ÞµðÄ®»ç¾÷ºÎ
    ¢ßÈÞ¸Õ¸ÞµðÅØ ±â¾÷ºÎ¼³¿¬±¸¼Ò
    °æºÏ´ë À¯Àü°øÇבּ¸¼Ò
    ¿µ³²´ë »ý¸í°øÇבּ¸¼Ò
    ¼­¿ï´ë È­ÇкÐÀÚ°øÇבּ¸´Ü
    ÀϺ» »ý¸í°øÇаø¾÷±â¼ú¿¬±¸¼Ò
    £¿ ÀÚ°Ý
    ±â¼ú°Å·¡»ç (»ê¾÷Åë»óÀÚ¿øºÎ)
    ±â¼ú»ç¾÷°¡Ä¡Æò°¡»ç (±â¼ú°Å·¡»çȸ)
    Á¤ºÎÁö¿ø»ç¾÷ °ËÅäÀ§¿ø ¹× Æò°¡À§¿ø
    âÁ¶°æÁ¦Å¸¿î(¾ÆÀ̵ð¾î¸¶·ç) Áö½Ä±âºÎÇü ¸àÅä
    âÁ¶°æÁ¦Çõ½ÅŸ¿î ¿Â¶óÀÎ ¸àÅä
    Çѱ¹°úÇбâ¼úÁ¤º¸¿¬±¸¿ø À§¿ø
    £¿ ¼ö·á
    ¹ÙÀÌ¿À±â¼úÅõÀÚ ¼ö·á (±âº»°úÁ¤, ½ÉÈ­°úÁ¤, Àü¹®°¡ °úÁ¤)
    ¿£Á©¾ÆÄ«µ¥¹Ì Àû°Ý¿£Á© ¾ç¼º°úÁ¤ ¼ö·á (¿£Á©ÅõÀÚÇùȸ)
    âÁ¶°¡µð¾ð½º ¸àÅä½± ¼ö·á
    º¥Ã³±â¾÷Çùȸ(SVI)-±âº»ÀÌ °­ÇÑ º¥Ã³ â¾÷Çϱ⠼ö·á
    º¥Ã³Æ÷Æ®-â¾÷ ¾ÆÄ«µ¥¹Ì ¼ö·á
    ÇѾç´ë-ÇѾ罺ŸƮ¾÷ ¾ÆÄ«µ¥¹Ì ¼ö·á
    ÀÌÈ­¿©´ë-ÀÌÈ­½ºÅ¸Æ®¾÷ ¾ÆÄ«µ¥¹Ì ¼ö·á
    ¿¬¼¼´ë-±â¼úâ¾÷ ¾ÆÄ«µ¥¹Ì ¼ö·á
    ÀÇ·á±â±â CE MDD ISO 13485 ³»ºÎ½É»ç¿ø
    ÀÇ·á±â±â ¹× ÀǾàǰ °ü·Ã GMP Á¦¹Ý°úÁ¤ ¼ö·á
    Medical Device Clinical Trial for FDA ¼ö·á
    £¿ Àú¼­/³í¹®
    ±â¼ú±ÝÀ¶ À̾߱â, Çѱ¹ÇмúÁ¤º¸ (2019)
    °æ±âÅ×Å©³ëº§¸®ÀÇ ¹ßÀü¹æ¾È ¿¬±¸, °æ±âµµ (2017)
    Á¦ÁÖµµ ÆÊÆÄ½º°ïÃæ·£µå »ç¾÷Ÿ´ç¼º ¿¬±¸, ³×ÀÌó¿ùµå¢ß (2017)
    Áß¼Ò±â¾÷À» À§ÇÑ Á¤ºÎÁö¿ø»ç¾÷ ´ëÀÀÀü·«, Ä®·³ 10Æí, AIST (2017)
    ±â¼ú°¡Ä¡Æò°¡ 8°Ç (2019)
    »ý¸í°øÇÐ ¹× È­ÇÐ ºÐ¾ß ÇмúÁö 12Æí

    ÀúÀÚ : ¹ÚÁؼö
    £¿ °æ·Â
    ºñ¿¡½ºÅõÀÚÆÄÆ®³Ê½º ÆÄÆ®³Ê (ÇöÀç)
    ¼øÃµÇâ´ëÇб³ »êÇÐÇùµ¿°´¿ø±³¼ö (ÇöÀç)
    Çѱ¹±â¼ú°Å·¡»çȸ ºÎȸÀå (ÇöÀç)
    ÇѾç´ëÇб³ / ¼÷¸í¿©ÀÚ´ëÇб³ / ¼øÃµÇâ´ëÇб³ »êÇб³¼ö
    ÀüºÏÅ×Å©³ëÆÄÅ© ±â¾÷Áö¿ø´ÜÀå
    Ãæ³²Å×Å©³ëÆÄÅ© ±â¾÷Áö¿ø´ÜÀå
    ¼­¸°¹ÙÀÌ¿À»çÀ̾𽺠ÀÌ»ç
    Çѱ¹º¥Ã³ÅõÀÚ ÅõÀÚºÎÀå (ÅõÀÚ 116°Ç, KOSDAQ 39°Ç, NASDAQ 2°Ç)
    ¾ÆÁÖ¾ÆÀ̺ñÅõÀÚ ¿µ¾÷ºÎÀå
    ½Å¿ëº¸Áõ±â±Ý Çà¿ø
    £¿ Àú¼­/³í¹®
    ±â¼ú±ÝÀ¶ À̾߱â, Çѱ¹ÇмúÁ¤º¸
    ¼¼°è¼ÓÀÇ ¼Ò»ó°øÀÎ, Çѱ¹ÇмúÁ¤º¸
    Death-Valley ±Øº¹À» À§ÇÑ ±â¼ú»ç¾÷È­ ÅõÀÚ°è¾à Çٽɰ¡À̵å, ÀÌ´ãºÏ½º
    ½ºÅ¸Æ®¾÷´ë»óÀÇ Á¤ºÎÀÚ±ÝÁö¿ø°³¼±¹æ¾È, Áß¼Ò±â¾÷À¶ÇÕÇÐȸ
    ¹Ì¹éÈ­Àåǰ ±¹³»¿Ü ½ÃÀå°æÀï·Â È®º¸¹æ¾È, ±¹Á¦Áö¿ªÇÐȸ
    ƯÇãÃëµæ°ø½Ã°¡ ±â¾÷°¡Ä¡¿¡ ¹ÌÄ¡´Â ¿µÇâ, ´Ü±¹´ë
    £¿ ÅõÀÚ ÇÁ·ÎÁ§Æ®
    Start-Up º¥Ã³ÆÝµå, 300¾ï¿ø °á¼º¡¤¿î¿ë Áß (ÇöÀç)
    ´Ù»êº¥Ã³ÆÝµå, 5°Ç 1,170¾ï¿ø °á¼º¡¤¿î¿ë
    ±â¼ú°¡Ä¡Æò°¡, 8°Ç (2019)
    £¿ ǥâ/ÀÚ°Ý
    »ê¾÷Åë»ó»ê¾÷ºÎÀå°ü ǥâ, ±ÝÀ¶Áö¿ø (2019)
    Áö½Ä°æÁ¦ºÎÀå°ü ǥâ, ±â¼ú»ç¾÷È­ (2009)
    Áß¼Ò±â¾÷ûÀå ǥâ, Áß¼Òº¥Ã³±â¾÷À°¼º (2009)
    ±â¼ú°Å·¡»ç/±â¼ú°¡Ä¡Æò°¡»ç/Á¤ºÎÁö¿ø»ç¾÷ Æò°¡À§¿ø
    £¿ ÇзÂ/¼ö·á
    KAIST AIM ÃÖ°í°æ¿µÀÚ°úÁ¤ ¼ö·á
    È޳ݸ¶ÄÉÆÃMBA/ÈÞ³ÝÀü·«MBA ¼ö·á
    ´Ü±¹´ëÇб³ ´ëÇпø, °æ¿µÇйڻç (À繫)
    ÇѾç´ëÇб³ ´ëÇпø, °øÇм®»ç (ÀüÀÚÅë½Å)
    ¼­°­´ëÇб³ ´ëÇпø, °æÁ¦Çм®»ç(±ÝÀ¶°æÁ¦)
    ¼þ½Ç´ëÇб³ ´ëÇпø, °æ¿µÇм®»ç(Áß¼Ò±â¾÷°æ¿µÁöµµ)
    ¼­¿ï½Ã¸³´ëÇб³ °æ¿µÇаú, °æ¿µÇлç
    ÀüÁÖ»ó¾÷°íµîÇб³

    ¸ñÂ÷

    CHAPTER 1. Á¤ºÎÁö¿ø»ç¾÷ÀÇ °³¿ä
    1. Áö¿ø»ç¾÷ÀÇ °³¿ä
    £¿£¿ Áö¿ø»ç¾÷ÀÇ ½ÇÈ¿¼º
    £¿£¿ Áö¿ø»ç¾÷ÀÇ ³­À̵µ
    £¿£¿ Áö¿ø»ç¾÷ÀÇ °æÀï·ü
    £¿£¿ »ç¾÷°èȹ¼­ÀÇ ¿ëµµ
    £¿£¿ ÅõÀÚÀÇ À¯Ä¡
    £¿£¿ ÄÁ¼³ÆÃ¿¡ ´ëÇÑ Á¶¾ð
    £¿£¿ ÀúÀÚÀÇ ´ëÇ¥¼º
    £¿£¿ ÁýÇÊÀÇ ¼±¾ð

    2. Áö¿ø»ç¾÷ÀÇ °ü¸®
    £¿£¿ Á¤ºÎÁö¿ø»ç¾÷ Àü¹®±â°ü
    £¿£¿ ¼öÇà±â°ü
    £¿£¿ R&D ¹× ºñR&D Áö¿ø»ç¾÷ÀÇ ºñ±³
    £¿£¿ ºñR&D Áö¿ø»ç¾÷¿¡ ´ëÇÑ °ßÇØ
    £¿£¿ ÃßõÇÏ°í ½ÍÀº ºñR&D Áö¿ø»ç¾÷
    £¿£¿ Æò°¡¿¡¼­ ºñ¸®
    £¿£¿ Æò°¡À§¿øÀÇ ÀÚ°Ý
    £¿£¿ Æò°¡À§¿øÀÇ °üÁ¡

    3. »ç¾÷°èȹ¼­ÀÇ °³¿ä
    £¿£¿ »ç¾÷°èȹ¼­ ¾ç½ÄÀÇ ºñ±³
    £¿£¿ »ç¾÷Áöħ
    £¿£¿ °ø°í¹®
    £¿£¿ 3Ã¥5°ø
    £¿£¿ Âü¿©À²
    £¿£¿ CAGR
    £¿£¿ ½ÃÀ强°ú »ç¾÷¼º
    £¿£¿ »ç¾÷¼º ºÐ¼®À» À§ÇÑ DB

    4. »ç¾÷°èȹ¼­ÀÇ ÀÛ¼º¿ä·É
    £¿£¿ °³Á¶½Ä
    £¿£¿ °¡½ÃÈ­¿Í °­Á¶
    £¿£¿ ¼öÄ¡¿Í ±Ù°Å
    £¿£¿ Anchoring
    £¿£¿ ¼±Á¤µÇ·Á ÇÏÁö ¸»°í Å»¶ôÇÏÁö ¾ÊÀ¸·Á


    CHAPTER 2. Á¤ºÎÁö¿ø»ç¾÷ÀÇ Áö¿ø
    1. ¼­¸éÆò°¡ £¿ ±â¼ú¼º
    £¿£¿ ±â¼ú°³¹ßÀÇ °³¿ä ¹× Çʿ伺
    £¿£¿ °³¹ß±â¼úÀÇ µ¶Ã¢¼º ¹× Â÷º°¼º
    £¿£¿ ±â¼ú°³¹ß ÁغñÇöȲ
    £¿£¿ ±â¼ú°³¹ß ¸ñÇ¥ ¹× ³»¿ë
    £¿£¿ ÁÖ¿ä ¿¬±¸ÀηÂ
    £¿£¿ ¿¬±¸½Ã¼³ Àåºñº¸À¯ ¹× ±¸ÀÔÇöȲ

    2. ¼­¸éÆò°¡ £¿ »ç¾÷¼º
    £¿£¿ »ç¾÷È­ ¸ñÇ¥
    £¿£¿ »ç¾÷È­ °èȹ
    £¿£¿ °í¿ëÀ¯Áö ¹× °í¿ëâÃâ °èȹ

    3. ¼­¸éÆò°¡ £¿ »ç¾÷ºñ

    4. ´ë¸éÆò°¡ £¿ ¹ßÇ¥ÀÚ·áÀÇ ÀÛ¼º
    £¿£¿ ¹ßÇ¥ÀÚ·áÀÇ °³¿ä
    £¿£¿ ½Ã³ª¸®¿ÀÀÇ Áغñ
    £¿£¿ ¹ßǥȯ°æ

    5. ´ë¸éÆò°¡ £¿ ¹ßÇ¥
    £¿£¿ PT ¼ø¼­ ¿Ü¿ì±â
    £¿£¿ Script ÀÛ¼º
    £¿£¿ FAQ
    £¿£¿ ¹ßÇ¥ ½Ã¹Ä·¹À̼Ç
    £¿£¿ ¸¶Áö¸· 30ÃÊ ¹ß¾ð
    £¿£¿ ´ë¸é¹ßÇ¥ÀÇ Âü°í
    £¿£¿ ´ë¸é¹ßÇ¥ÀÇ Æò°¡Àå
    £¿£¿ ´ë¸é¹ßÇ¥ÀÇ È¯°æ
    £¿£¿ ´ë¸é¹ßÇ¥ÀÇ ¸¶Áö¸· Á¶¾ð


    CHAPTER 3. Á¤ºÎÁö¿ø»ç¾÷ÀÇ ¼öÇà
    1. Áö¿ø»ç¾÷ÀÇ ¼öÇà
    £¿£¿ »ó¼¼ ÀÏÁ¤Ç¥
    £¿£¿ »ó¼¼ ÁöÃâÇ¥
    £¿£¿ »ç¾÷ºñÀÇ ¼ÒÁø
    £¿£¿ ¼öÇà ÁßÀÇ º¯°æ
    £¿£¿ ¿¬±¸³ëÆ®ÀÇ ÀÛ¼º
    £¿£¿ ¼öÇà °á°ú¹°ÀÇ »ç»ç
    £¿£¿ Æò°¡ÁöÇ¥ÀÇ °øÀνÃÇè
    £¿£¿ Æò°¡ÁöÇ¥ÀÇ ÀÚü½ÃÇè
    £¿£¿ ÃÖÁ¾º¸°í¼­
    £¿£¿ ÃÖÁ¾Á¡°Ë

    2. Áö¿ø»ç¾÷ÀÇ Âü°í»çÇ×µé
    £¿£¿ »ç¾÷°èȹ¼­ ÀÛ¼º¾÷¹«ÀÇ ºÐ´ã
    £¿£¿ ¹ßÇ¥ÀÚ·áÀÇ ÀÛ¼º
    £¿£¿ »ç¾÷ºñ
    £¿£¿ ´ë¸éÆò°¡
    £¿£¿ ±âŸ ÁÖÀÇ»çÇ×
    £¿£¿ À¯¿ëÇÑ ¼ÒÇÁÆ®¿þ¾î 3Á¾ Ãßõ
    £¿£¿ µµÀå À̹ÌÁöÀÇ Áßø
    £¿£¿ ¸¶Ä¡¸é¼­

    Âü°í¹®Çå

    ¹è¼Û ½Ã À¯ÀÇ»çÇ×

    - ¹Ýµð¾Ø·ç´Ï½º¿¡¼­ ±¸¸ÅÇϽеµ¼­´Â ¹°·ù ´ëÇà À§Å¹¾÷ü ¿õÁø ºÏ¼¾À» ÅëÇØ ¹è¼ÛµË´Ï´Ù.
     (¹è¼Û Æ÷Àå¿¡ "¿õÁø ºÏ¼¾"À¸·Î Ç¥±âµÉ ¼ö ÀÖ½À´Ï´Ù.)

    - ±¸¸ÅÇÑ »óǰÀÇ Ç°Áú°ú ¹è¼Û °ü·Ã ¹®ÀÇ´Â ¹Ýµð¾Ø·ç´Ï½º·Î ¹®ÀÇ ¹Ù¶ø´Ï´Ù.

    - õÀçÁöº¯ ¹× Åùè»çÀÇ »çÁ¤¿¡ µû¶ó ¹è¼ÛÀÌ Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù.

    - °áÁ¦(ÀÔ±Ý) ¿Ï·á ÈÄ ÃâÆÇ»ç ¹× À¯Åë»çÀÇ »çÁ¤À¸·Î ǰÀý ¶Ç´Â ÀýÆÇ µÇ¾î »óǰ ±¸ÀÔÀÌ ¾î·Á¿ï ¼ö ÀÖ½À´Ï´Ù. (º°µµ ¾È³» ¿¹Á¤)

    - µµ¼­»ê°£Áö¿ªÀÇ °æ¿ì Ãß°¡ ¹è¼Ûºñ°¡ ¹ß»ýµÉ ¼ö ÀÖ½À´Ï´Ù.

    ¹Ýǰ/±³È¯

    »óǰ ¼³¸í¿¡ ¹Ýǰ/ ±³È¯ °ü·ÃÇÑ ¾È³»°¡ ÀÖ´Â °æ¿ì ±× ³»¿ëÀ» ¿ì¼±À¸·Î ÇÕ´Ï´Ù. (¾÷ü »çÁ¤¿¡ µû¶ó ´Þ¶óÁú ¼ö ÀÖ½À´Ï´Ù)

    ¹Ýǰ/±³È¯

    ¹Ýǰ/±³È¯
    ¹Ýǰ/±³È¯ ¹æ¹ý Ȩ > °í°´¼¾ÅÍ > ÀÚÁÖã´ÂÁú¹® ¡°¹Ýǰ/±³È¯/ȯºÒ¡± ¾È³» Âü°í ¶Ç´Â 1:1»ó´ã°Ô½ÃÆÇ
    ¹Ýǰ/±³È¯ °¡´É ±â°£ ¹Ýǰ,±³È¯Àº ¹è¼Û¿Ï·á ÈÄ 7ÀÏ À̳», »óǰÀÇ °áÇÔ ¹× °è¾à³»¿ë°ú ´Ù¸¦ °æ¿ì ¹®Á¦¹ß°ß ÈÄ 30ÀÏ À̳»¿¡ ½Åû°¡´É
    ¹Ýǰ/±³È¯ ºñ¿ë º¯½É ȤÀº ±¸¸ÅÂø¿ÀÀÇ °æ¿ì¿¡¸¸ ¹Ý¼Û·á °í°´ ºÎ´ã(º°µµ ÁöÁ¤ Åùè»ç ¾øÀ½)
    ¹Ýǰ/±³È¯ ºÒ°¡ »çÀ¯
    • ¼ÒºñÀÚÀÇ Ã¥ÀÓ »çÀ¯·Î »óǰ µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì
    • ¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óǰ µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
    • º¹Á¦°¡ °¡´ÉÇÑ »óǰ µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì : ¿¹)¸¸È­Ã¥, ÀâÁö, È­º¸Áý µî
    • ½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆÇ¸Å°¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
    • ÀüÀÚ»ó°Å·¡µî¿¡¼­ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì
    • ÇØ¿ÜÁÖ¹® »óǰ(ÇØ¿Ü ¿ø¼­)ÀÇ °æ¿ì(ÆÄº»/ÈѼÕ/¿À¹ß¼Û »óǰÀ» Á¦¿Ü)
    ¼ÒºñÀÚ ÇÇÇØº¸»ó
    ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó
    • »óǰÀÇ ºÒ·®¿¡ ÀÇÇÑ ¹Ýǰ, ±³È¯, A/S, ȯºÒ, ǰÁúº¸Áõ ¹× ÇÇÇØº¸»ó µî¿¡ °üÇÑ »çÇ×Àº
      ¼ÒºñÀÚ ºÐÀïÇØ°á ±âÁØ(°øÁ¤°Å·¡À§¿øÈ¸°í½Ã)¿¡ ÁØÇÏ¿© 󸮵Ê
    • ´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ
      ¼ÒºñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ
    ¹Ýǰ/±³È¯ ÁÖ¼Ò °æ±âµµ ÆÄÁֽà ¹®¹ß·Î 77, ¿õÁøºÏ¼¾(¹Ýµð¾Ø·ç´Ï½º)
    • ȸ»ç¸í : (ÁÖ)¼­¿ï¹®°í
    • ´ëÇ¥ÀÌ»ç : ±èÈ«±¸
    • °³ÀÎÁ¤º¸ º¸È£Ã¥ÀÓÀÚ : ±èÈ«±¸
    • E-mail : bandi_cs@bnl.co.kr
    • ¼ÒÀçÁö : (06168) ¼­¿ï °­³²±¸ »ï¼º·Î 96±æ 6
    • »ç¾÷ÀÚ µî·Ï¹øÈ£ : 120-81-02543
    • Åë½ÅÆÇ¸Å¾÷ ½Å°í¹øÈ£ : Á¦2023-¼­¿ï°­³²-03728È£
    • ¹°·ù¼¾ÅÍ : (10881) °æ±âµµ ÆÄÁֽà ¹®¹ß·Î 77 ¹Ýµð¾Ø·ç´Ï½º
    copyright (c) 2016 BANDI&LUNI'S All Rights Reserved